danazol has been researched along with Helicobacter Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, GJ; Choi, YJ; Chung, JS; Shin, HJ; Song, MK | 1 |
| Asahi, A; Ikeda, Y; Kawakami, Y; Kuwana, M; Masaoka, T; Nishimoto, T; Okazaki, Y; Suzuki, H | 1 |
| Farkas, H; Fekete, B; Füst, G; Karádi, I; Varga, L | 1 |
1 trial(s) available for danazol and Helicobacter Infections
| Article | Year |
|---|---|
Outcome of immunosuppressive therapy with Helicobacter pylori eradication therapy in patients with chronic idiopathic thrombocytopenic purpura.
Topics: Adult; Aged; Anti-Bacterial Agents; Chronic Disease; Danazol; Drug Therapy, Combination; Estrogen Antagonists; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Steroids; Treatment Outcome | 2008 |
2 other study(ies) available for danazol and Helicobacter Infections
| Article | Year |
|---|---|
Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients.
Topics: Aged; Blood Platelets; Breath Tests; Cohort Studies; Danazol; Female; Glucocorticoids; Helicobacter Infections; Helicobacter pylori; Humans; Kinetics; Male; Middle Aged; Monocytes; Platelet Count; Prednisolone; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Receptors, IgG; Urea | 2008 |
Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema.
Topics: Abdominal Pain; Adult; Angioedema; Antibodies, Bacterial; Complement C1 Inactivator Proteins; Danazol; Estrogen Antagonists; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male | 2001 |